Home > Protocol Summaries: Compounds > gabapentin enacarbil

Protocol Summaries: gabapentin enacarbil

Protocol Summaries for gabapentin enacarbil
GSK
Study ID		 Phase Title Status
110448 phase 2 Study PXN110448: A dose-response study of XP13512, compared with concurrent placebo control and LYRICA(pregabalin), in subjects with neuropathic pain associated with diabetic peripheral neuropathy (DPN) Completed
110527 phase 2 Study PXN110527: The investigation of the efficacy and pharmacokinetics of XP13512 in subjects with neuropathic pain associated with post-herpetic neuralgia (PHN) who have had an inadequate response to gabapentin treatment. Completed
110748 phase 2 Study PXN110748: An efficacy and safety study of XP13512 compared with a concurrent placebo control in subjects with neuropathic pain associated with post-herpetic neuralgia (PHN) Completed
110882 Phase 1 An open-label, randomized, single dose, five-period crossover study to evaluate the relative bioavailability of different formulations of GSK1838262 in healthy volunteers. Completed
111381 Phase 2 Study MPX111381: A dose-ranging study evaluating the efficacy, safety and tolerability of GSK1838262 (XP13512)in the prophylactic treatment of migraine headache Completed
111460 Phase 3 A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of XP13512 in Patients With Restless Legs Syndrome. Completed
111461 Phase 3 A Long-Term Study of XP13512 Versus Placebo Treatment Assessing Maintenance of Efficacy and Safety in Patients With Restless Legs Syndrome. Completed
111490 Phase 3 An Open-Label, 52-Week Extension Study Assessing XP13512 Safety and Efficacy in Patients With Restless Legs Syndrome. Completed
114427 Risk of pancreatic cancer and renal cancer in patients exposed to gabapentin in the United Kingdom General Practice Research Database Active, not recruiting
RXP110908 Phase 3 Study RXP110908, a polysomnography study of GSK1838262 (XP13512) extended release tablets versus placebo in the treatment of Restless Legs Syndrome (RLS) and associated sleep disturbance Completed

Filter list by: